Literature DB >> 21042948

Hepatic stellate cells accelerate the malignant behavior of cholangiocarcinoma cells.

Hirohisa Okabe1, Toru Beppu, Hiromitsu Hayashi, Takatoshi Ishiko, Toshiro Masuda, Ryu Otao, Hasita Horlad, Hirohumi Jono, Mitsuharu Ueda, Satoru Shinriki, Yukio Ando, Hideo Baba.   

Abstract

BACKGROUND: Although tumor-stromal interaction has been discussed, the role of hepatic stellate (HS) cells against cancer, especially cholangiocarcinoma (CC), has not been clarified. The aim of this study is to investigate the effect of HS cells on CC cell progression in vitro and in vivo.
METHODS: The effects of CC conditioned medium (CC-CM) on activation and proliferation of HS cells (LI90 and LX-2), the influences of HS cell CM (HS-CM) on proliferation and invasion of CC cells (HuCCT-1 and RBE), and the effects of their interaction on HUVEC tube formation were assessed using each CM. The effect of HS cells on tumor growth was examined in vivo by subcutaneous co-injection. Cytokine array was performed to assess the secreted proteins induced by their coculture.
RESULTS: CC-CM activated HS cells and increased their proliferation. HS-CM dose-dependently increased CC cell proliferation and invasion. Chemotherapy of CC cells was less effective when treated with HS-CM. HS-CM activated the mitogen-activated protein kinase and Akt pathways in tumor cells. The indirect interaction of CC and HS cells promotes tube formation of human umbilical venous endothelial cells. Subcutaneous co-injection of tumor cells with HS cells in nude mouse resulted in increased tumor size. Several proteins were found in the culture medium induced by their coculture, thought to be key proteins which regulated tumor-stromal interaction.
CONCLUSIONS: This study indicates that HS cells play an important role in accelerating cholangiocarcinoma progression and may be a therapeutic target in cholangiocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21042948     DOI: 10.1245/s10434-010-1391-7

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  21 in total

Review 1.  The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma.

Authors:  Alphonse E Sirica
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-11-29       Impact factor: 46.802

Review 2.  Liver metastases: Microenvironments and ex-vivo models.

Authors:  Amanda M Clark; Bo Ma; D Lansing Taylor; Linda Griffith; Alan Wells
Journal:  Exp Biol Med (Maywood)       Date:  2016-07-06

3.  Extracellular vesicles carry microRNA-195 to intrahepatic cholangiocarcinoma and improve survival in a rat model.

Authors:  Ling Li; Klaus Piontek; Masaharu Ishida; Michel Fausther; Jonathan A Dranoff; Rongdang Fu; Esteban Mezey; Stephen J Gould; Francis K Fordjour; Stephen J Meltzer; Alphonse E Sirica; Florin M Selaru
Journal:  Hepatology       Date:  2016-08-29       Impact factor: 17.425

4.  The expression levels of CD44v6 are correlated with the invasiveness of hepatocellular carcinoma in vitro, but do not appear to be clinically significant.

Authors:  Kosuke Mima; Hirohisa Okabe; Takatsugu Ishimoto; Hiromitsu Hayashi; Shigeki Nakagawa; Hideyuki Kuroki; Keisuke Miyake; Hiroshi Takamori; Toru Beppu; Hideo Baba
Journal:  Oncol Lett       Date:  2012-02-17       Impact factor: 2.967

Review 5.  Membrane-to-Nucleus Signals and Epigenetic Mechanisms for Myofibroblastic Activation and Desmoplastic Stroma: Potential Therapeutic Targets for Liver Metastasis?

Authors:  Ningling Kang; Vijay H Shah; Raul Urrutia
Journal:  Mol Cancer Res       Date:  2014-12-29       Impact factor: 5.852

Review 6.  Hepatic stellate cells: partners in crime for liver metastases?

Authors:  Ningling Kang; Gregory J Gores; Vijay H Shah
Journal:  Hepatology       Date:  2011-08       Impact factor: 17.425

7.  Epithelial-mesenchymal transition expression profiles as a prognostic factor for disease-free survival in hepatocellular carcinoma: Clinical significance of transforming growth factor-β signaling.

Authors:  Kosuke Mima; Hiromitsu Hayashi; Hideyuki Kuroki; Shigeki Nakagawa; Hirohisa Okabe; Akira Chikamoto; Masayuki Watanabe; Toru Beppu; Hideo Baba
Journal:  Oncol Lett       Date:  2012-10-05       Impact factor: 2.967

8.  Novel organotypic culture model of cholangiocarcinoma progression.

Authors:  Deanna J W Campbell; Catherine I Dumur; Nadia F Lamour; Jennifer L Dewitt; Alphonse E Sirica
Journal:  Hepatol Res       Date:  2012-05-09       Impact factor: 4.288

9.  Unveiling the role of tumor reactive stroma in cholangiocarcinoma: an opportunity for new therapeutic strategies.

Authors:  Massimiliano Cadamuro; Stuart Duncan Morton; Mario Strazzabosco; Luca Fabris
Journal:  Transl Gastrointest Cancer       Date:  2013-07

10.  CXCR4/TGF-β1 mediated hepatic stellate cells differentiation into carcinoma-associated fibroblasts and promoted liver metastasis of colon cancer.

Authors:  Hao-Xiang Tan; Wei-Zhi Gong; Kai Zhou; Zhi-Gang Xiao; Fu-Tao Hou; Tao Huang; Ling Zhang; Hong-Yu Dong; Wei-Lin Zhang; Yu Liu; Zhong-Cheng Huang
Journal:  Cancer Biol Ther       Date:  2019-12-11       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.